The MHRA recently published an update on its plans for MedTech regulatory change. The update confirmed that the new framework will be introduced through four statutory instruments to update and replace the UK Medical Devices Regulations 2002. The UK government has confirmed that a statutory instrument, which will set out new rules for Post Market Surveillance (PMS) which will strengthen requirements for vigilance and surveillance of products on the market is expected to be laid in Parliament…
By: McDermott Will & Emery
By: McDermott Will & Emery